| James E Lang, MD | |
|
4800 Ne 20th Ter, Suite 305, Ft Lauderdale, FL 33308-4510 | |
| (954) 491-1111 | |
| (954) 491-7017 |
| Full Name | James E Lang |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 4800 Ne 20th Ter, Ft Lauderdale, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811945868 | NPI | - | NPPES |
| 25290 | Other | FL | INDIVIDUAL BCBS |
| 990010758 | Other | FL | RAILROAD MEDICARE |
| 34713 | Other | FL | GROUP BCBS |
| 375460000 | Medicaid | FL | |
| 650642257 | Other | FL | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME65330 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Cross Hospital | Fort lauderdale, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| James E Lang Md Pa | 4587751938 | 4 |
News Archive
Analog Devices, Inc. (ADI) today announced that Lantronix, Inc. has selected ADI's iCoupler digital isolator technology to enable its new family of wireless communication network servers.
A new lab-based study has shown that when airway cells damaged by cigarette smoke are exposed instead to glo vapor, the biological effects caused by smoke exposure are reversed.
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
› Verified 7 days ago
| Entity Name | James E Lang Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780616276 PECOS PAC ID: 4587751938 Enrollment ID: O20071101000020 |
News Archive
Analog Devices, Inc. (ADI) today announced that Lantronix, Inc. has selected ADI's iCoupler digital isolator technology to enable its new family of wireless communication network servers.
A new lab-based study has shown that when airway cells damaged by cigarette smoke are exposed instead to glo vapor, the biological effects caused by smoke exposure are reversed.
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James E Lang, MD 4800 Ne 20th Ter, Suite 305, Ft Lauderdale, FL 33308-4510 Ph: (954) 491-1111 | James E Lang, MD 4800 Ne 20th Ter, Suite 305, Ft Lauderdale, FL 33308-4510 Ph: (954) 491-1111 |
News Archive
Analog Devices, Inc. (ADI) today announced that Lantronix, Inc. has selected ADI's iCoupler digital isolator technology to enable its new family of wireless communication network servers.
A new lab-based study has shown that when airway cells damaged by cigarette smoke are exposed instead to glo vapor, the biological effects caused by smoke exposure are reversed.
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
› Verified 7 days ago
Dr. Eric Charles Gechter, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 2900 W Cypress Creek Rd, Suite 1, Ft Lauderdale, FL 33309 Phone: 954-977-0192 Fax: 954-977-0197 | |
Daniel Gologorsky, MD, MBA Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1625 Se 3rd Ave Ste 501, Ft Lauderdale, FL 33316 Phone: 954-468-8072 Fax: 954-468-8087 | |
Patrick E Rubsamen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6333 N Federal Hwy, Suite 300, Ft Lauderdale, FL 33308 Phone: 954-776-6880 Fax: 954-229-3100 | |
Dr. Krista D Rosenberg, Ophthalmology Medicare: Medicare Enrolled Practice Location: 6333 N Federal Hwy, Suite 300, Ft Lauderdale, FL 33308 Phone: 954-776-6880 Fax: 954-229-3100 | |
George A Fournier, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2466 E Commercial Blvd, Ft Lauderdale, FL 33308 Phone: 954-492-1177 Fax: 954-492-0352 | |
Dr. Robert Lee Kramm Iii, MD, MSE Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1281 S Ocean Dr, Ft Lauderdale, FL 33316 Phone: 720-252-8488 | |
John F Sciarrino, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5601 N. Dixie Hwy, Ste 115, Ft Lauderdale, FL 33334 Phone: 954-771-4271 Fax: 954-776-5959 |